These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12658770)

  • 1. Study on the effects of FCu-IUD and FICu-IUD on matrix metalloproteinases in human uterine flushing and endometrium.
    Li W; Cao L; Chen Z; Li W; Du Q; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):9-11, 16. PubMed ID: 12658770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium].
    Xin ZM; Xie QZ; Cao LM; Sun YP; Su YC; Guo YH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):771-5. PubMed ID: 15634506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical experimental studies of indomethacin-releasing copper intrauterine device.
    Cao L; Zhou Y; Liu Z; Du Q; Li W; Hu Y; Li W
    J Tongji Med Univ; 2000; 20(3):249-52. PubMed ID: 11215063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary morphometric study on the endometrium from patients treated with indomethacin-releasing copper intrauterine device.
    Zhao G; Li M; Zhu P; Xu R; Wang J; Xu R
    Hum Reprod; 1997 Jul; 12(7):1563-6. PubMed ID: 9262297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three dimensional reconstruction of human endometrial spiral arteries preinsertion and postinsertion of IUD].
    Huang L; Chen L; Chen Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):523-5. PubMed ID: 9275421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
    Wang IY; Russell P; Fraser IS
    Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
    Yin M; Zhu P; Luo H; Xu R
    Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in effect of copper and ProgestasertR IUDS on fibrinolytic activity of the endometrium in the rabbit.
    Liedholm P; Sjöberg NO
    Contraception; 1979 May; 19(5):443-8. PubMed ID: 467053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphometric study of endometrial spiral arterioles before and after insertion of gamma CuI and TCu 220C intrauterine devices].
    Liu Z; Chen Q; Ni X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):232-4. PubMed ID: 10682472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine device use among women with uterine fibroids: a systematic review.
    Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins].
    Zhang JY; Luo LL
    Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):167-8, 190. PubMed ID: 1395902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
    Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
    Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subendometrial microvascularization and uterine artery blood flow in IUD-induced side effects (levonorgestrel intrauterine system and copper intrauterine device).
    Jiménez MF; Vetori D; Fagundes PA; de Freitas FM; Cunha-Filho JS
    Contraception; 2008 Oct; 78(4):324-7. PubMed ID: 18847582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrial cytology with a new copper-containing IUD (ML Cu 250) (proceedings)].
    Herting W; Tauber PF; Kurz E
    Arch Gynakol; 1977 Jul; 224(1-4):34-5. PubMed ID: 579844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.